Related Experiment Videos
Cerebrospinal fluid markers that predict SIV CNS disease
J L Mankowski1, S E Queen, J E Clements
1Department of Comparative Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jmankows@jhmi.edu
Journal of Neuroimmunology
|December 8, 2004
Summary
Predictive biomarkers in cerebrospinal fluid, such as IL-6, MCP-1, and viral RNA, can track HIV CNS disease progression. Elevated levels during asymptomatic infection indicate severe SIV encephalitis development.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- Cerebrospinal fluid (CSF) biomarkers are crucial for monitoring HIV central nervous system (CNS) disease.
- Identifying predictive markers can aid in understanding disease development and progression.
Purpose of the Study:
- To quantitate expression of IL-6, MCP-1, and viral RNA in CSF of SIV-infected macaques.
- To determine if these markers correlate with the severity of SIV encephalitis across infection stages.
Main Methods:
- CSF samples were collected from SIV-inoculated macaques.
- Levels of IL-6, MCP-1, and SIV RNA were measured during acute, asymptomatic, and terminal infection stages.
- Quantification was performed to assess correlation with SIV encephalitis severity.
Main Results:
- Animals with moderate to severe SIV encephalitis showed significantly elevated CSF IL-6, MCP-1, and SIV RNA.
- These elevated marker levels were observed during the asymptomatic phase and persisted through terminal disease.
- A clear parallel was found between marker levels and the severity of CNS disease.
Conclusions:
- CSF IL-6, MCP-1, and SIV RNA are potential predictive biomarkers for HIV CNS disease.
- These markers can help track the development and progression of SIV encephalitis.
- Early detection of elevated markers may predict severe neurological outcomes in HIV infection.